-----------To download Application Form Click Here -----------
Latest Update
Program Overview
Pharmaceutical Industry is the biggest beneficiary of Bioinformatics revolution. It has been found that pharmaceutical companies can simultaneously save significant money and time by integrating data and information across disciplines, pharmaceutical departments, processes and drugs. We are now moving into an era where drugs may be designed as per individual genetic profiles. Bioinformatics is now providing to be a powerful tool in the battle against toxicity and last-stage drug failures.
Along with Bioinformatics discovery, development, marketing & manufacture of drugs is being transformed because of another change which is introduction of new patent systems & future multiple patent expires.
This program is aimed at equipping professional respond to the above changes. The program is suitable for professionals & pharma students alike.
Program Objectives
- To be the biggest knowledge enhancement movement in the world in the area of Drug Design and Patenting.
- To spread, enhance and share knowledge in the emerging areas of Drug Design and Patenting.
- To provide quality inputs in the area of Drug Design and Patenting to working professionals and individuals who have completed their education and willing to contribute in this area.
- To develop documentation / research writing expertise in the Drug Design and Patenting Domain.
- To equip participants of the BII Industry Program in Drug Design and Patenting to be able to spread awareness in this area by sharing their knowledge with others.
- To be a platform for interchange and exchange of knowledge in this
area by organizing interaction between program members through BII Blog.
Program Methodology
- Prospective Participants join the program by submitting
admission form with necessary participation fee.
- Delivery of Program Kits and Support material to the
participant.
- The participant will go through the program kit and support
material by himself and through BII's centralized support.
- The participant with the support of BII and his own initiative will
participate in the program by:
- Self Study of Program Kit and other helping material
- Time Bound Preparation of a Research Report on the allocated topic
through BII and his own resources (e.g employer, academic institution,
library, internet etc). Submission of Research Report to BII .
- Time Bound Completion and Submission self analysis work books to
BII .
- Interacting with other participating members and organizations through BII Blog at http://www.biinoida.blogspot.com
- Spreading awareness about Drug Design and Patenting area with others through knowledge sharing.
- Time Bound Completion of the Program
- Receiving Citation & Experience Certificate from BII about objectives achieved during the program.
Program Areas
Deliverables
Program Deliverables include:
Training Kits comprising of Reference Materials and Free Lecture CDs, Support via Internet, Email and Telephone and Information exchange via BII Blog.
BII Lecture CDs
BII Courseware
How To Join
In order to join BII Industry Program on Program on Drug Design and Patenting prospective participant has to submit the necessary Application form. Down Load Now
BII Blog
BII Blog - is an open interactive knowledge platform
for you. It is meant to be a platform "Of the Participants, for the
Participants by BII". BII Blog will provide the following facilities:
- Knowledge interchange and exchange among the users.
- Web based resources.
- Information sharing on jobs, events etc.
- Other activities of mutual interest among the users.
So, through this Synchronous Discussions - computer mediated communication
(CMC) participants are able to communicate with other participants of the Institute
to share news, views, comments and opportunities in the domain area.
BII Blog is available on
website. The link is http://www.biinoida.blogspot.com. All program participants are provided access to BII Blog.
Eligibility
The eligibilty for the training program is graduation in any discipline.Highly interested participants in final year can also apply.
Program Fee
BII Program Participation Fee for this program is Rs 10000 (for participants based in India / USD 750 ( for overseas participants ). Payment is to be made through Demand Draft / Telegraphic Transfer in favor of Bioinformatics Institute of India
Examination Fees
Every student has to pay Rs.200/- per module as examination fees . Examination fee for overseas participants is USD 25 Per Module
Program Duration
The program duration is 12 months.
Some of our students are associated with the following renowned companies
| Company Name |
Company Name |
| N.R. Vekaria Institute |
Sun Pharma |
| Crompton Greaves Ltd. |
Sesa Goa Ltd. |
| DAV College |
BBMB Hospital Chandigarh |
| UV Vitamins |
Dr. Reddy's Lab |
| Stride Arcolab Ltd |
MSPL Ltd. |
| Vaidik Remedies, Nagpur |
Cosme Pharma |
| Reliance Life Sciences |
Clonegen Biotech |
| Baxter India Pvt Ltd |
HPL Faridabad |
| Sri Krishna Pharma |
Panacea Biotech |
| Elder Pharma Ltd. |
Glaxosmithkline |
| Lupin Ltd. |
AIIMS |
| Sysmed Pharma |
Bio-Rad Laboratories |
| TTK Pharmaceutical |
J.B.Roy State Ayurvedic Hospital |
| Bio-Rad Laboratories |
Ranbaxy Lab Ltd. |
| Aurobindo Pharma |
Cadila Pharmaceuticals Ltd. |
| Pfizer Ltd |
L&T Information Technology Ltd. |
| Novartis India Ltd. |
Polaris Software Lab Ltd. |
| Wipro Technologies Ltd. |
Infosys Technologies Ltd. |
| Merck India |
Charak Pharmaceuticals |
| Gujrat Ayurved Unvit |
Evaluation
At the end of the duration of a program, participants go through a well defined evaluation process which is held on all India basis.
-----------To download Application Form Click Here -----------
For further details and enquiries :
| India
| Overseas |
Program Co-ordinator Industry Program in Drug Design and Patenting
Bioinformatics Institute of India
C-56 A/28, Sector - 62 Noida - 201301, UP(INDIA)
Tel : 0120 - 4320801/02
Mob : 09810535368
|
Dr. Kumud Sarin
INTERNATIONAL ACADEMIC COUNSELLOR
+91-9811420055 |
| E-mail : info@bioinformaticscentre.org
| Email: global@bii.in |